| Reaction Details |
|---|
 | Report a problem with these data |
| Target | 5-hydroxytryptamine receptor 1A |
|---|
| Ligand | BDBM50034346 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEBML_581 |
|---|
| Ki | 56±n/a nM |
|---|
| Citation |  Chidester, CG; Lin, CH; Lahti, RA; Haadsma-Svensson, SR; Smith, MW Comparison of 5-HT1A and dopamine D2 pharmacophores. X-ray structures and affinities of conformationally constrained ligands. J Med Chem36:1301-15 (1993) [PubMed] |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| 5-hydroxytryptamine receptor 1A |
|---|
| Name: | 5-hydroxytryptamine receptor 1A |
|---|
| Synonyms: | 5-HT-1A | 5-HT1A | 5-hydroxytryptamine receptor 1A (5-HT-1A) | 5HT1A_HUMAN | ADRB2RL1 | ADRBRL1 | Dopamine D2 receptor and serotonin 1a receptor | G-21 | HTR1A | Serotonin receptor 1A |
|---|
| Type: | n/a |
|---|
| Mol. Mass.: | 46122.49 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | n/a |
|---|
| Residue: | 422 |
|---|
| Sequence: | MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAA
IALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCC
TSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPED
RSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADT
RHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGN
SKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLP
FFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFC
RQ
|
|
|
|---|
| BDBM50034346 |
|---|
| n/a |
|---|
| Name | BDBM50034346 |
|---|
| Synonyms: | (3aS,9aR) 1-Allyl-2,3,3a,4,9,9a-hexahydro-1H-benzo[f]indol-5-ol | (3aS,9aR)-1-allyl-2,3,3a,4,9,9a-hexahydro-1H-benzo[f]indol-5-ol | 1-Allyl-2,3,3a,4,9,9a-hexahydro-1H-benzo[f]indol-5-ol | CHEMBL11363 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C15H19NO |
|---|
| Mol. Mass. | 229.3175 |
|---|
| SMILES | Oc1cccc2C[C@@H]3[C@H](CCN3CC=C)Cc12 |
|---|
| Structure | 
|
|---|
Search and Browse
